March 16, 2026 — RNews

#immunotherapy — Monday, March 16, 2026 (1 items)

hot top new

← prev day next day →

0

Pyrotinib or placebo in combination with trastuzumab and docetaxel for HER2 positive metastatic breast cancer: long term survival results from randomised phase 3 PHILA trial. (bmj.com)

Ma F … Xu B BMJ 2026-03-16

#cancer #clinical trial #immunotherapy #chemotherapy